Teva Czech Industries S.R.O.

FDA Regulatory Profile

Teva Czech Industries S.R.O. has 0 FDA recalls, 8 inspections, 0 510(k) clearances and 0 compliance actions on record.

Latest inspection
Aug 30, 2024 · VAI

Newer recall under related name Teva Pharmaceuticals Usa: Sep 29, 2026, D-0038-2027.

Reviewing Teva Czech Industries S.R.O. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Teva Czech Industries S.R.O. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections8Nov 8, 2026Newest record Oct 28, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Related names

NameRecalls510(k)InspectionsComplianceMost recent recall
Teva Pharmaceuticals Usa
Same company group
2810170Sep 29, 2026 (D-0038-2027)
Actavis Pharma
Same company group
1000Mar 16, 2016 (D-1060-2016)
Teva Pharmaceutical Industries
Same company group
10181Oct 20, 2015 (D-0521-2016)
Watson Laboratories
Same company group
220100Jan 15, 2014 (D-1053-2014)
Teva Canada Limited
Same company group
00190—
Teva Branded Pharmaceutical Products R And D
Same company group
00140—
Barr Laboratories
Same company group
00130—
Teva Parenteral Medicines
Same company group
00111—
Teva Womens Health
Same company group
00120—
Teva Puerto Rico
Same company group
0081—
Pliva Hrvatska
Same company group
0080—
Teva Api India Private
Same company group
0050—

Recent FDA Inspections

DateSiteProductClassificationFEI
Aug 30, 2024Opava, Czech RepublicDrugsVoluntary Action Indicated (VAI)1000282452
Sep 8, 2022Opava, Czech RepublicDrugsVoluntary Action Indicated (VAI)1000282452
Sep 17, 2020Opava, Czech RepublicDrugsVoluntary Action Indicated (VAI)1000282452
Sep 13, 2018Opava, Czech RepublicDrugsVoluntary Action Indicated (VAI)1000282452
Mar 24, 2017Opava, Czech RepublicDrugsVoluntary Action Indicated (VAI)1000282452
Mar 21, 2014Opava, Czech RepublicDrugsNo Action Indicated (NAI)1000282452
Sep 22, 2011Opava, Czech RepublicDrugsVoluntary Action Indicated (VAI)1000282452
Jun 1, 2010Opava, Czech RepublicDrugsNo Action Indicated (NAI)1000282452

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 1000282452Opava, Czech Republic8Aug 30, 2024

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.